Thank you This live web event has ended. Thank you for attending. Contributors Pankaj Aggarwal, Ph.D. (Pfizer) Pankaj received his PhD degree in analytical chemistry from Milton L. Lee lab at Brigham Young University. His thesis work was focused on developing high efficiency monolithic stationary phases for capillary HPLC by optimizing the stationary phase morphology. He implemented statistical DOE’s to optimize the morphology and thereby the chromatographic performance. Pankaj joined Pfizer in 2014 as Senior Scientist in QbD method development group within ARD. In this role, Pankaj have been developing analytical methods for HPLC and UPLC by applying QbD principles and computational approaches to ensure method robustness with minimum development time. Pankaj has been an active member of the Connecticut Separation Science Council (CSSC) since 2015. Olivier Mozziconacci, Ph.D. (Merck) Olivier received his Master of Sciences degree in Radiation Chemistry from the University of Orsay Paris XI and the Institute of Nuclear Physics. He joined the Marie Curie European doctoral program in collaboration with the University of Orsay Paris XI, the Institute of Nuclear Chemistry and Technology of Warsaw, Poland, and the Consiglio Nazionale delle Ricerche (CNR) in Bologna, Italy. Olivier completed his PhD studying the electron transfer mechanisms in enkephalins. Olivier also completed two postdoctoral fellowships at the Institute for Organic Synthesis and Photoreactivity in Italy (ISOF-CNR, Bologna) and at the Department of Pharmaceutical Chemistry at The University of Kansas, where he collaborated as a Research Associate with Prof. Christian Schöneich on stability studies and degradation mechanisms of proteins/drugs in biotechnology. After few years as a Research Professor at the University of Kansas, focusing on i) stability of protein-antibody, and biosimilars, ii) biological processes involving H-atom and/or Proton-Coupled Electron Transfer reactions initiated by sulfur-centered radicals, Olivier joined the department of Analytical Sciences at Merck in 2016 to support analytical-stability programs across various therapeutic molecules based in Rahway, NJ.